Skip to main content
Contact Us
Subscribe
E-Edition
53°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Livanova Plc OR Sh
(NQ:
LIVN
)
49.71
-0.79 (-1.56%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Livanova Plc OR Sh
< Previous
1
2
3
Next >
LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting
December 05, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences
November 14, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints
November 11, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova Reports Third-Quarter 2024 Results
October 30, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova Appoints Susan Podlogar as a New Director
October 08, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova to Announce Third-Quarter 2024 Results
September 25, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at the Baird Global Healthcare Conference
August 19, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova Reports Second-Quarter 2024 Results
July 31, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova to Announce Second-Quarter 2024 Results
June 18, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
June 06, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at the Goldman Sachs Healthcare Conference
May 23, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova Reports First-Quarter 2024 Results
May 01, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
April 30, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
April 25, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova to Announce First-Quarter 2024 Results
March 21, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
March 20, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
March 05, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
March 04, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at the Barclays Global Healthcare Conference
March 04, 2024
From
LivaNova
Via
Business Wire
LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
February 21, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director
February 05, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova to Wind Down Advanced Circulatory Support Business Unit
January 08, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results
January 04, 2024
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at the Piper Sandler Healthcare Conference
November 09, 2023
From
LivaNova PLC
Via
Business Wire
LivaNova Reports Third-Quarter 2023 Results
November 01, 2023
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at the Stifel and Wolfe Healthcare Conferences
October 25, 2023
From
LivaNova PLC
Via
Business Wire
LivaNova Board Appoints J. Christopher Barry as New Director
October 06, 2023
From
LivaNova PLC
Via
Business Wire
LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023
September 21, 2023
From
LivaNova PLC
Via
Business Wire
LivaNova to Announce Third-Quarter 2023 Results
September 20, 2023
From
LivaNova PLC
Via
Business Wire
LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE Mark
August 30, 2023
From
LivaNova PLC
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.